|
Cervical screening guidelines
|
Resource Development
|
CDC, FDA, HRSA
|
NCI
|
The National Cancer Institute (NCI) is generating risk estimates that inform cervical screening and management guidelines. NCI is working with CDC, HRSA, and FDA to collect study populations, conduct risk estimation, and disseminate guidelines.
|
|
Chemical Hazards Emergency Medical Management (CHEMM) Working Group
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NICHD, NINDS
|
The goal of CHEMM is to provide a comprehensive, user-friendly resource to help enable first responders and other healthcare providers to plan for, respond to, recover from, and mitigate the effects of mass-casualty incidents involving chemicals.https://chemm.hhs.gov/
|
|
CHESS Joint Oversight Group
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NIGMS
|
A Joint Oversight Group (JOG) was established to better coordinate the CHESS and MacCHESS awards. The JOG serves as a vehicle to keep interested parties informed and includes MPS, ENG, BIO, and NIH program directors.
|
|
Chief Freedom of Information Act (FOIA) Officers Council Technology Committee
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
OD/OCPL
|
In response to a recommendation of the 2016-2018 term of the FOIA Advisory Committee, the Archivist of the United States proposed that the Chief FOIA Officers (CFO) Council seek to establish a technology committee, in partnership with the Chief Information Officer (CFO) Council, to study the utilization and deployment of technology in FOIA programs across agencies, and identify best practices and recommendations that can be implemented across agencies.In September 2018, the CFO Council co-chairs established the Technology Subcommittee (later renamed as the Technology Committee). Two senior FOIA professionals at the Department of State and the Veterans Health Administration co-chair the Committee; membership includes FOIA professionals from the Departments of Homeland Security and the Interior, National Aeronautics and Space Administration (NASA), the National Institutes of Health (NIH), Institute of Library and Museum Services, American Battle Monuments Commission, Social Security Administration, Air Force Declassification Office, and the Consumer Financial Protection Bureau. The Committee liaises with OIP and OGIS.
|
|
Chronic Kidney Disease Surveillance System
|
Health Survey
|
CDC
|
NIDDK
|
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) assists the Centers for Disease Control and Prevention (CDC) in its surveillance program of chronic kidney disease, including taking part in an Advisory Group to provide feedback on the program.
|
|
Circulating Estrogens, Androgens, and Progestogens and Risk of Breast Cancer in the PLCO Cohort
|
Research Initiative
|
CDC
|
NCI
|
In a stratified cohort study of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), restricted to postmenopausal women not on menopausal hormone therapy, we are using a validated liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay recently developed by CDC to assess prediagnostic circulating levels of the endogenous steroid hormones believed to be involved in breast cancer etiology. Although it is known that endogenous hormones play a critical role in the etiology of breast cancer, the interrelationships among estrogens, androgens, and progesterone in determining risk are not well understood.
|
|
CISA: Clinical Immunization Safety Assessment Network
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NHLBI, NIAID
|
DAIT leadership and Allergy, Asthma and Airway Biology Branch personnel discussing with CDC findings from a recent CDC-funded study suggetive of an association between the amount of aluminum in infant vaccines and the incidence of asthma
|
|
ClinGen-FDA Recognized Human Variant Database
|
Resource Development
|
FDA
|
NCI, NEI, NHGRI, NICHD, NINDS
|
In April 2018, the FDA announced the initiation of a Public Human Genetic Variant Database program to support the agency’s precision medicine initiatives. A primary aim of the program is to foster innovation among test developers and advances in patient care through access to valid sources of accurate human variant interpretation data. Data and assertions within the database are considered to be valid scientific evidence that can be used to streamline the test development and validation processes. The NIH-funded Clinical Genome Resource (ClinGen) become the first FDA recognized database with a scope focused on germline variants in hereditary disease with a high likelihood the condition will manifest. ClinGen is currently working with the FDA to maintain this recognition.
|
|
Clinical and Rehabilitative Medicine Research Program (CRMRP) Scientific Working Group (SWG)
|
Committee, Work group, Advisory group, or Task Force
|
Not Reported
|
NIAMS
|
The JPC-8/CRMRP's mission is to focus on definitive and rehabilitative care innovations required to reset our wounded warriors, both in terms of duty performance and quality of life. The program has multiple initiatives to achieve its goals, including improving prosthetic function, enhancing self-regenerative capacity, improving limb/organ transplant success, creating full functioning limbs/organs, repairing damaged eyes, treating visual dysfunction following injury, improving pain management, and enhancing rehabilitative care. https://cdmrp.health.mil/dmrdp/jpc8crmrp
|
|
Clinical and Translational Serology Task Force
|
Resource Development
|
ASPR, CDC, FDA
|
NCI, NIAID
|
The National Cancer Institute established a taskforce to catalyze translation of research findings into public health changes. The task force brings together government, academia and industry to provide relevant tools and information related to serology testing to help decisionmakers manage the current and future status of the SARS-CoV-2 pandemic. The task force includes scientists from several disciplines, clinicians, regulatory and public policy experts, and patient advocates.
|